Skin Cancer Treatment at Illinois Dermatology Institute
Your leader in the fight against skin cancer.
At IDI, we understand the uncertainty that can come with a cancer diagnosis. Whether you’re living with skin cancer or have recently discovered a mole, an unusual area of patchy skin, or have a painful sore, we are here to help diagnose and treat your condition.
One in five people in the United States will receive a skin cancer diagnosis in their lifetime.
Being proactive about dermatology examinations, self-exams, education, and prevention are all strategic ways to beat the odds.
If you are one in five, you’re not alone.
Our experts can get you on the road to recovery faster with the latest prevention methods, advanced diagnosis and treatment options, and long-term skin care plans. Don’t delay treatment.

Proactive patient education and routine exams are essential to early detection.
Early detection is critical when it comes to a skin cancer diagnosis and treatment plan that conquers cancer. At IDI, we encourage routine dermatology visits. During these exams, we focus on patient education. We help you understand the signs and symptoms of skin changes that could signal skin cancer in yourself or your loved ones.
We encourage those who have a medical or family history of cancer to get screened early. When detected in good time and treated effectively, the rate of remission is exceptionally high.
IDI offers the most state-of-the-art treatment methods for all forms of skin cancer, including Mohs surgery and superficial radiation therapy. Learn more about our treatment options here.
Understanding your skin cancer diagnosis

Every day, skin cells die, and new ones form to replace them in a process controlled by DNA. Skin cancer can develop when this process does not work properly because of damage to DNA. New cells may form when they are not needed, or older cells may not die. This can cause a growth of tissue known as a tumor. DNA damage is often a result of ultraviolet radiation.
Explore varying types of skin cancer below.